-
Je něco špatně v tomto záznamu ?
Developmental programming of growth: genetic variant in GH2 gene encoding placental growth hormone contributes to adult height determination
Y. Timasheva, M. Putku, R. Kivi, V. Kožich, J. Männik, M. Laan,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, metaanalýza, práce podpořená grantem
Grantová podpora
070191/Z/03/A
Wellcome Trust - United Kingdom
- MeSH
- dospělí MeSH
- frekvence genu MeSH
- genetické asociační studie MeSH
- index tělesné hmotnosti MeSH
- jednonukleotidový polymorfismus * MeSH
- lidé středního věku MeSH
- lidé MeSH
- multigenová rodina MeSH
- placentární hormony genetika metabolismus MeSH
- růstový hormon genetika metabolismus MeSH
- senioři MeSH
- těhotenství MeSH
- tělesná výška MeSH
- vazebná nerovnováha MeSH
- vývoj kostí * MeSH
- vývoj plodu * MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- metaanalýza MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Baškortostán MeSH
- Česká republika MeSH
- Estonsko MeSH
INTRODUCTION: Given the physiological role of placental growth hormone (PGH) during intrauterine development and growth, genetic variation in the coding Growth hormone 2 (GH2) gene may modulate developmental programming of adult stature. Two major GH2 variants were described worldwide, determined by single polymorphism (rs2006123; c.171 + 50C > A). We sought to study whether GH2 variants may contribute to adult anthropometric measurements. METHODS: Genotyping of GH2 SNP rs2006123 by RFLP, testing its genetic association with adult height and Body Mass Index (BMI) by linear regression analysis, and combining the results of three individual study samples in meta-analysis. STUDY SAMPLES: HYPEST (Estonia), n = 1464 (506 men/958 women), CADCZ (Czech), n = 871 (518/353); UFA (Bashkortostan), n = 954 (655/299); meta-analysis, n = 3289 (1679/1610). RESULTS: Meta-analysis across HYPEST, CADCZ and UFA samples (n = 3289) resulted in significant association of GH2 rs2006123 with height (recessive model: AA-homozygote effect: beta (SE) = 1.26 (0.46), P = 5.90 × 10⁻³; additive model: A-allele effect: beta (SE) = 0.45 (0.18), P = 1.40 × 10⁻²). Among men (n = 1679), the association of the A-allele with taller stature remained significant after multiple-testing correction (additive effect: beta = 0.86 (0.28), P = 1.83 × 10⁻³). No association was detected with BMI. Notably, rs2006123 was in strong LD (r² ≥ 0.87) with SNPs significantly associated with height (rs2665838, rs7209435, rs11658329) and mapped near GH2 in three independent meta-analyses of GWA studies. CONCLUSIONS: This is the first study demonstrating a link between a placental gene variant and programming of growth potential in adulthood. The detected association between PGH encoding GH2 and adult height promotes further research on the role of placental genes in prenatal programming of human metabolism.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20014869
- 003
- CZ-PrNML
- 005
- 20200929120907.0
- 007
- ta
- 008
- 200922s2013 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.placenta.2013.08.012 $2 doi
- 035 __
- $a (PubMed)24035309
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Timasheva, Y $u Human Molecular Genetics Group, Institute of Molecular and Cell Biology, University of Tartu, Riia St. 23, Tartu 51010, Estonia; Institute of Biochemistry and Genetics, Ufa Scientific Centre of Russian Academy of Sciences, Ufa, Russia.
- 245 10
- $a Developmental programming of growth: genetic variant in GH2 gene encoding placental growth hormone contributes to adult height determination / $c Y. Timasheva, M. Putku, R. Kivi, V. Kožich, J. Männik, M. Laan,
- 520 9_
- $a INTRODUCTION: Given the physiological role of placental growth hormone (PGH) during intrauterine development and growth, genetic variation in the coding Growth hormone 2 (GH2) gene may modulate developmental programming of adult stature. Two major GH2 variants were described worldwide, determined by single polymorphism (rs2006123; c.171 + 50C > A). We sought to study whether GH2 variants may contribute to adult anthropometric measurements. METHODS: Genotyping of GH2 SNP rs2006123 by RFLP, testing its genetic association with adult height and Body Mass Index (BMI) by linear regression analysis, and combining the results of three individual study samples in meta-analysis. STUDY SAMPLES: HYPEST (Estonia), n = 1464 (506 men/958 women), CADCZ (Czech), n = 871 (518/353); UFA (Bashkortostan), n = 954 (655/299); meta-analysis, n = 3289 (1679/1610). RESULTS: Meta-analysis across HYPEST, CADCZ and UFA samples (n = 3289) resulted in significant association of GH2 rs2006123 with height (recessive model: AA-homozygote effect: beta (SE) = 1.26 (0.46), P = 5.90 × 10⁻³; additive model: A-allele effect: beta (SE) = 0.45 (0.18), P = 1.40 × 10⁻²). Among men (n = 1679), the association of the A-allele with taller stature remained significant after multiple-testing correction (additive effect: beta = 0.86 (0.28), P = 1.83 × 10⁻³). No association was detected with BMI. Notably, rs2006123 was in strong LD (r² ≥ 0.87) with SNPs significantly associated with height (rs2665838, rs7209435, rs11658329) and mapped near GH2 in three independent meta-analyses of GWA studies. CONCLUSIONS: This is the first study demonstrating a link between a placental gene variant and programming of growth potential in adulthood. The detected association between PGH encoding GH2 and adult height promotes further research on the role of placental genes in prenatal programming of human metabolism.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a tělesná výška $7 D001827
- 650 _2
- $a index tělesné hmotnosti $7 D015992
- 650 12
- $a vývoj kostí $7 D001846
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a vývoj plodu $7 D047109
- 650 _2
- $a frekvence genu $7 D005787
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 _2
- $a růstový hormon $x genetika $x metabolismus $7 D013006
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a vazebná nerovnováha $7 D015810
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a multigenová rodina $7 D005810
- 650 _2
- $a placentární hormony $x genetika $x metabolismus $7 D010926
- 650 12
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a těhotenství $7 D011247
- 651 _2
- $a Baškortostán $7 D001486
- 651 _2
- $a Česká republika $7 D018153
- 651 _2
- $a Estonsko $7 D004957
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a metaanalýza $7 D017418
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Putku, M
- 700 1_
- $a Kivi, R
- 700 1_
- $a Kožich, V
- 700 1_
- $a Männik, J
- 700 1_
- $a Laan, M
- 773 0_
- $w MED00003835 $t Placenta $x 1532-3102 $g Roč. 34, č. 11 (2013), s. 995-1001
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24035309 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200922 $b ABA008
- 991 __
- $a 20200929120903 $b ABA008
- 999 __
- $a ok $b bmc $g 1567729 $s 1105029
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 34 $c 11 $d 995-1001 $e 20130829 $i 1532-3102 $m Placenta $n Placenta $x MED00003835
- GRA __
- $a 070191/Z/03/A $p Wellcome Trust $2 United Kingdom
- LZP __
- $a Pubmed-20200922